Category Archives: People

Appili Therapeutics Announces Receipt from NIAID of a Notice of Termination for Convenience on the Contract for the VXV-01 Program

HALIFAX, Nova Scotia, July 03, 2026 (GLOBE NEWSWIRE) — Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases today announced that it has received a Notice of Termination for Convenience from the National Institute of Allergy and Infectious Diseases (“NIAID”), part of the […]

Court Approval of a Restructuring Transaction Allowing Continuation of Uninterrupted Operations

MONTREAL, July 03, 2026 (GLOBE NEWSWIRE) — PREMIER HEALTH OF AMERICA INC. (TSX-V: PHA) (“Premier Health” or the “Company”) announces that, in connection with the proceedings initiated on June 23, 2026 by the Royal Bank of Canada (the “Applicant”) in its capacity as a secured creditor (the “CCAA Proceedings”), the Québec Superior Court (Commercial Division) (the […]

Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08

NEW YORK, July 03, 2026 (GLOBE NEWSWIRE) — Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today announced that it issued an inducement award to a new employee. Effective July 1, 2026, in connection with commencing employment as Head of Product of BetterHelp, David Packles was granted an award of restricted stock […]

American Indian College Fund Welcomes Six New Members and Student Representatives to the Board of Trustees

Three-year Term to Begin July 1, 2026 Denver, Colo., July 02, 2026 (GLOBE NEWSWIRE) — The American Indian College Fund has appointed two tribal colleges presidents and two private sector professionals to the governing board of trustees. Two student representatives have also been selected. The incoming board members are: Dr. Brad Hall, President of Blackfeet Community […]

Jelly Force Male Enhancement Gummies Release Latest Formula for Men: JellyForce Unique Ingredient Profile Report

Muira Puama, Maca, Ashwagandha, and L-Arginine Blend: Supplement Facts, Sourcing, and Consumer Safety Considerations Explained Pinellas Park, FL, July 02, 2026 (GLOBE NEWSWIRE) — These statements have not been evaluated by the Food and Drug Administration. JellyForce is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before use, […]

Loblaw Companies Limited Announces the Timing of the Second Quarter 2026 Earnings Release

BRAMPTON, Ontario, July 02, 2026 (GLOBE NEWSWIRE) — Loblaw Companies Limited (TSX: L) announced today that it will release its 2026 second quarter results on July 30th, 2026, at approximately 6:30 a.m. (ET). The release will be followed by a conference call at 10:00 a.m. (ET), as well as an audio webcast. To access via […]

Guest Supply Signs Asia-Pacific Licensing Agreement with HAAN

HONG KONG, July 02, 2026 (GLOBE NEWSWIRE) — Guest Supply Asia today announced a licensing agreement with HAAN to manufacture and distribute HAAN-branded personal care products for hotels across Asia Pacific. The agreement combines HAAN’s design-led, refillable approach to personal care with Guest Supply’s product development, manufacturing, distribution and service capabilities for hotel operators. It […]

Vivani Announces Entry into Merger Agreement Between Wholly Owned Subsidiary Cortigent, Inc. and Nasdaq-listed ClearOne, Inc.

Vivani proposes to merge Cortigent, Inc. with a wholly owned subsidiary of ClearOne, Inc. (Nasdaq: CLRO), and change the listed company’s name and ticker to Cortigent Holdings, Inc. (d/b/a Cortigent) and “CRGT” Cortigent is a leading developer of brain computer interface (“BCI”) devices based on precision neurostimulation technology ALAMEDA, Calif., July 02, 2026 (GLOBE NEWSWIRE) […]

YD Bio Expands U.S. Laboratory Footprint to 46 States, Strengthening DNA-Methylation Early Cancer Detection Operations

Taipei, Taiwan, July 02, 2026 (GLOBE NEWSWIRE) — YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation–based cancer detection technology and ophthalmologic innovations, today announced that its affiliate, EG BioMed US Inc., a Delaware corporation (“EG BioMed US”), has obtained out-of-state clinical laboratory licenses in Rhode Island and […]

OnKure Therapeutics to Host Virtual KOL Event to Discuss PI3Kα Inhibitor Medicines: Selectivity Matters & Pan-Mutant Allosteric Inhibition Delivers, on July 15, 2026

BOULDER, Colo., July 02, 2026 (GLOBE NEWSWIRE) — OnKure Therapeutics, Inc. (Nasdaq: OKUR), a clinical-stage biopharmaceutical company focused on developing novel precision medicines, today announced that it will host a virtual key opinion leader (KOL) event on Wednesday, July 15, 2026 at 11:00 AM ET featuring Benjamin F. Cravatt, PhD (The Scripps Research Institute) and […]